Meridian Bioscience Inventory

Meridian Bioscience (VIVO) currently reports a inventory of $73M as of December 2022. That compares with $74M in the prior-year period — down 2.1% year over year. Use the charts on this page to explore Meridian Bioscience's inventory history and peer comparisons.

Meridian Bioscience's inventory decreased from $74M to $73M — a 2.1% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Meridian Bioscience reported $73M in inventory as of December 2022. That compares with $74M in the prior-year period — down 2.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $73M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Meridian Bioscience, and consider following VIVO for alerts when major investors trade the stock.

Meridian Bioscience is classified in the Healthcare sector. On inventory, it currently shows $73M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VIVO with unrelated industries.